Gemcitabine: all 1,575 studies that test it

Page 14 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
• Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerCompletedNCT00193362Phase 3
• Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsCompletedNCT00193323Phase 2
• Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerCompletedNCT00193076Phase 2
• Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerCompletedNCT00192712Phase 2/3
• Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCompletedNCT00192101Phase 2
• A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNCT00192062Phase 2
• A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCompletedNCT00192049Phase 2
• 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCompletedNCT00191971Phase 2
• Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCompletedNCT00191841Phase 2
• Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCompletedNCT00191763Phase 2
• Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.CompletedNCT00191711Phase 2
• A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
• Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.CompletedNCT00191620Phase 2
• Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00191568Phase 2
• Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCompletedNCT00191503Phase 2
• A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCompletedNCT00191490Phase 2
• Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
• A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCompletedNCT00191373Phase 2
• A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCompletedNCT00191347Phase 2
• Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
• Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCompletedNCT00191243Phase 2
• Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung CancerCompletedNCT00191230Phase 2
• Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCCompletedNCT00191126Phase 3
• A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCompletedNCT00190710Phase 3
• Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00182806Phase 2
• A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the PancreasTerminatedNCT00179751Phase 1/2
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
• Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerTerminatedNCT00176241Phase 1
• Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCCCompletedNCT00173862Phase 2
• Study of Metastatic Ocular MelanomaStatus unknownNCT00168870Phase 2
• Efficacy and Treatment Related Toxicity Study of a New Regimen for LymphomaCompletedNCT00163748Phase 2
• Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.TerminatedNCT00159471Not applicable
• Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast CancerTerminatedNCT00159458Phase 2
• Capecitabine and Gemcitabine in Patients With Metastatic Colorectal CancerCompletedNCT00159445Phase 2
• Phase I/II Trial GOFL in Advanced Pancreatic AdenocarcinomaCompletedNCT00154791Phase 1/2
• Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00154739Phase 2
• Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
• Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung CancerStatus unknownNCT00150657Phase 2
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2
• Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
• Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder CancerStatus unknownNCT00146276Phase 3
• Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue SarcomaCompletedNCT00142571Phase 3
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderCompletedNCT00136175Phase 2
• Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
• Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
• Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer PatientsCompletedNCT00128310Phase 3
• Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial TractTerminatedNCT00127595Phase 2
• Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell TumorsStatus unknownNCT00127049Phase 2
• Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00126633Phase 2
• Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown PrimaryStatus unknownNCT00126269Phase 3
• Gemcitabine and Cisplatin for Gallbladder and Biliary Tract CancerCompletedNCT00123825Phase 2
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary OriginWithdrawnNCT00119314Phase 2
• Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTerminatedNCT00116389Phase 2
• Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate CancerCompletedNCT00115635Phase 1/2
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00114179Phase 2
• Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00112710Phase 3
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112346Phase 2
• Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerCompletedNCT00103051Phase 2
• Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in CancerCompletedNCT00102752Phase 1/2
• Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian CancerCompletedNCT00102414Phase 3
• Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder CancerCompletedNCT00101842Phase 1/2
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNCT00101127Phase 2
• Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast CancerCompletedNCT00100750Phase 1/2
• Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian CancerCompletedNCT00096395Phase 2
• Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00096070Phase 2
• Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00095966Phase 2
• 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTerminatedNCT00095888Phase 2
• Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00090909Phase 2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's LymphomaCompletedNCT00086801Phase 2
• Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderCompletedNCT00084942Phase 2
• Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic CancerStatus unknownNCT00082862Phase 2
• Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantActive, not recruitingNCT00082706Phase 2
• Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNCT00080795Phase 2
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasStatus unknownNCT00079365Not applicable
• Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00079352Phase 1
• Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00079261Phase 2
• Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland TumorCompletedNCT00079079Phase 2
• 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
• GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
• 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00077415Phase 2
• A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
• Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00075751Phase 2
• Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00075517Phase 2
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaStatus unknownNCT00075452Phase 3
• Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT GemcitabineTerminatedNCT00074607Phase 1
• Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00074204Phase 3
• Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
• Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
• Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsWithdrawnNCT00072228Phase 1
• Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00071136Phase 1/2
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00070304Phase 2
• Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
• A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCompletedNCT00069875Phase 2
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerCompletedNCT00066768Phase 1

← Gemcitabine overview